LE
Lilly Endowment INC
Concentrated strategySector-focusedLong-term holder
Total reported value
$84.5B
Reporting period: 2026-03-31 · Number of holdings: 1
LILLY ENDOWMENT INC disclosed 1 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $84.5B and a quarterly turnover rate of 15.9%.
Personality snowflake
- Concentration
- 100
- Portfolio Stability
- 15.85
- Momentum/Contrarian
- 50
- Sector conviction
- 100
- Diversification
- 2
- Sizing Uniformity
- —
Recent moves
Unchanged LLY
-0.3% -$14.6B
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | Stock-Healthcare | 100.00% | — | -0.32% |
Reported value over time
Sector allocation
Sector allocation over time
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 1 | $84.5B | 16 | |
| 2025-12-31 | 1 | $99.1B | 30 | |
| 2025-09-30 | 1 | $72.9B | 9 | |
| 2025-06-30 | 1 | $74.8B | 0 | |
| 2025-03-31 | 1 | $79.3B | 100 | |
| 2024-12-31 | 1 | $74.8B | 0 | |
| 2024-09-30 | 1 | $85.8B | 0 | |
| 2024-06-30 | 1 | $88.2B | 0 | |
| 2024-03-31 | 1 | $76.9B | 0 | |
| 2023-12-31 | 1 | $58.2B | 0 | |
| 2023-09-30 | 1 | $53.7B | 0 | |
| 2023-06-30 | 1 | $47.4B | 0 | |
| 2023-03-31 | 1 | $35.2B | 0 | |
| 2022-12-31 | 1 | $37.7B | 0 | |
| 2022-09-30 | 1 | $33.6B | 0 | |
| 2022-06-30 | 1 | $33.8B | 0 | |
| 2022-03-31 | 1 | $30.4B | 0 | |
| 2021-12-31 | 1 | $29.7B | 0 | |
| 2021-09-30 | 1 | $25.0B | 0 | |
| 2021-06-30 | 1 | $25.1B | 90 | |
| 2021-03-31 | 1 | $20.6B | 9 | |
| 2020-12-31 | 1 | $18.8B | 13 | |
| 2020-09-30 | 1 | $16.4B | 11 | |
| 2020-06-30 | 1 | $18.3B | 15 | |
| 2020-03-31 | 1 | $15.7B | 4 | |
| 2019-12-31 | 1 | $15.1B | 14 | |
| 2019-09-30 | 1 | $13.0B | 1 | |
| 2019-06-30 | 1 | $12.9B | 16 | |
| 2019-03-31 | 1 | $15.2B | 10 | |
| 2018-12-31 | 1 | $13.7B | 6 | |
| 2018-09-30 | 1 | $12.8B | 21 | |
| 2018-06-30 | 1 | $10.4B | 9 | |
| 2018-03-31 | 1 | $9.5B | 9 | |
| 2017-12-31 | 1 | $10.4B | 2 | |
| 2017-09-30 | 1 | $10.6B | 3 | |
| 2017-06-30 | 1 | $10.2B | 3 | |
| 2017-03-31 | 1 | $10.5B | 13 | |
| 2016-12-31 | 1 | $9.2B | 9 | |
| 2016-09-30 | 1 | $10.1B | 1 | |
| 2016-06-30 | 1 | $10.0B | 8 | |
| 2016-03-31 | 1 | $9.2B | 16 | |
| 2015-12-31 | 1 | $10.8B | 1 | |
| 2015-09-30 | 1 | $10.8B | 0 | |
| 2015-06-30 | 1 | $10.8B | 13 | |
| 2015-03-31 | 1 | $9.5B | 5 | |
| 2014-12-31 | 1 | $9.1B | 5 | |
| 2014-09-30 | 1 | $8.6B | 3 | |
| 2014-06-30 | 1 | $8.3B | 4 | |
| 2014-03-31 | 1 | $8.0B | 14 | |
| 2013-12-31 | 1 | $6.9B | 1 | |
| 2013-09-30 | 1 | $6.8B | 2 | |
| 2013-06-30 | 1 | $6.7B | 0 |
Holding changes this quarter
Lilly Endowment INC's most significant position changes for 2026-03-31: Trim: Eli Lilly & Co (LLY) — shares -0.32%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | — | -0.32% | Trim |
FAQ
What is Lilly Endowment INC and what type of investor is it?
Lilly Endowment INC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately $84.5B, spread across 1 disclosed positions.
What are Lilly Endowment INC's largest equity positions?
Based on the latest 13F filing, Lilly Endowment INC's top holdings by market value are:
1. Eli Lilly & Co (LLY) — $84.5B (100.0%)
What changes did Lilly Endowment INC make in its most recent portfolio filing?
In the latest quarter, Lilly Endowment INC took a more defensive posture — trimming 1 positions and completely exiting 0 holdings. The largest of these moves: Trim: Eli Lilly & Co (LLY) — shares -0.32%
What sectors does Lilly Endowment INC focus on?
Lilly Endowment INC is concentrated in the following sectors based on its current disclosed equity portfolio:
• Health Care: 100.0%